BiVictriX
Biotech focused on developing novel, highly-selective, bispecific ADCs to target unmet need in blood cancer.
BiVictriX has raised €8.8M across 1 funding round from 1 investor, most recently a round in Aug 2021. Based in Alderley Edge, UK; active in Healthtech. Data as of 28 Oct 2026.
Alderley Edge, UKwww.bivictrix.com ↗
Total raised
€8.8M
€8,836,733
Funding rounds
1
Investors
1
distinct backers
Active since
2021-08
latest 2021-08
Funding by year
EUR raised per yearBiVictriX — funding by year — interactive chart.
Data table
| BiVictriX — funding by year | |
|---|---|
| 2021 | €8.8M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-16 | Other | €8.8M | Slater Heelis | View deal → |